Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Odonate Therapeutics Inc (NQ: ODT )

19.35 USD -1.70 (-8.08%)
Official Closing Price Updated: 7:54 PM EST, Mar 1, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Odonate Therapeutics Inc

< Previous 1 2 3 4 5 6 Next >
Odonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2020
Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced... 
From Business Wire News Releases
Odonate Therapeutics, Inc. (NASDAQ:ODT) Long Term Shareholder Notice: Investigation of Potential Wrongdoing
San Diego, CA -- (SBWIRE) -- 01/13/2021 -- Certain directors of Odonate Therapeutics, Inc. are under investigation concerning potential breaches of fiduciary duties. 
From SBWire - Latest Press Releases
Notable Insider Buys Of The Past Week: Danimer Scientific, Cheniere Energy Partners And More
Insider buying can be an encouraging signal for potential investors when markets face uncertainty. Insider purchases at a special ... 
Tags IQV IEP Kroger
From Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Hepion Pharmaceuticals (NASDAQ:HEPA) stock increased by 14.9% to $2.39 during Tuesday's after-market session. At the ... 
Tags MTP HEPA General
From Benzinga
70 Biggest Movers From Thursday
Gainers Air T, Inc. (NASDAQ: AIRT) shares jumped 293.6% to close at $38.38 on Thursday after the company announced plans to form a ... 
Tags ENG BLNK AVGR
From Benzinga
Notable Insider Buys In The Week Of Christmas: Foot Locker, GameStop, NetApp And More
Insider buying can be an encouraging signal for potential investors when markets face uncertainty. Insider purchases of ... 
Tags Eos Energy Enterprises CURI GME
From Benzinga
42 Stocks Moving In Thursday's Mid-Day Session
Gainers Air T, Inc. (NASDAQ: AIRT) gained 85.6% to $18.10 after the company announced plans to form a new aircraft equity vehicle. ... 
Tags Market News PHAR ONTX
From Benzinga
Thinking about buying stock in Gevo Inc, Inovio Pharmaceuticals, Odonate Therapeutics, Cocrystal Pharma, or Vuzix Corp?
InvestorsObserver issues critical PriceWatch Alerts for GEVO, INO, ODT, COCP, and VUZI. 
From PR Newswire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Avinger (NASDAQ:AVGR) shares moved upwards by 98.26% to $0.69 during Thursday's pre-market session. The ... 
Tags TNXP AVGR CHEK
From Benzinga
BeyondSpring Announces the Appointment of Dr. Jeffrey Vacirca to its Board of Directors
From GlobeNewswire News Releases
Noteworthy Friday Option Activity: ODT, ISRG, CYH
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Odonate Therapeutics Inc (ODT), where a total volume of 1,924 contracts has been... 
Tags Stocks
From Market News Video
Positive Results of CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic Breast Cancer, Presented at the 2020 San Antonio Breast Cancer Symposium (SABCS)
Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best‑in‑class therapeutics that improve and extend the lives of patients with cancer, today announced... 
From Business Wire News Releases
The Daily Biotech Pulse: Pfizer-BioNTech Receive FDA Panel Backing, Sanofi-GSK Disclose Delay In Vaccine Program, 4 Biotechs To Debut On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags FREQ NMTR PRTK
From Benzinga
Odonate Therapeutics Initiates Cohort 3 of CONTESSA TRIO to Evaluate Tesetaxel Monotherapy in Patients with Metastatic Breast Cancer
Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced... 
From Business Wire News Releases
The Math Shows IEIH Can Go To $38
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Odonate Therapeutics to Host Virtual Investor and Analyst Event on December 11, 2020
Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced... 
From Business Wire News Releases
ODT Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Odonate Therapeutics, Inc. Shareholders With Losses Exceeding $50K of Class Action and Lead Plaintiff Deadline: November 16, 2020
Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Odonate Therapeutics, Inc. ("Odonate" or the "Company") (NASDAQ: ODT) and certain of its... 
From Business Wire News Releases
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Odonate Therapeutics, Inc. 
From Business Wire News Releases
FINAL DEADLINE ALERT: ROSEN, A TOP RANKED LAW FIRM, Reminds Odonate Therapeutics, Inc. Investors of Important Monday Deadline in Securities Class Action – ODT
From GlobeNewswire News Releases
ODT FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Reminds Odonate Therapeutics, Inc. Investors of Important Monday Deadline in Securities Class Action - ODT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Odonate Therapeutics, Inc. (NASDAQ: ODT) between December 7, 2017 and August 21, 2020, inclusive (the "Class... 
From PR Newswire
SHAREHOLDER DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against Odonate Therapeutics, Inc.– ODT; IMPORTANT NOV. 16 DEADLINE- ODT
From GlobeNewswire News Releases
ODT STOCK ALERT: Zhang Investor Law Announces Securities Class Action Lawsuit Against Odonate Therapeutics, Inc. – ODT
From GlobeNewswire News Releases
NASDAQ:ODT Shareholder Notice: Deadline on November 16, 2020 in Lawsuit Against Odonate Therapeutics, Inc.
San Diego, CA -- (SBWIRE) -- 11/11/2020 -- A deadline is coming up on November 16, 2020 in the lawsuit filed for certain investors of Odonate Therapeutics, Inc. (NASDAQ:ODT) over alleged securities... 
From SBWire - Latest Press Releases
ODT, NNOX & GOCO Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Odonate Therapeutics, Inc. and of Class Action Lawsuit and Upcoming Deadline – ODT
From GlobeNewswire News Releases
ROSEN, NATIONAL TRIAL LAWYERS, Reminds Odonate Therapeutics, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm –
From GlobeNewswire News Releases
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Reminds Odonate Therapeutics, Inc. Investors of Important Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K
From GlobeNewswire News Releases
ODT, NNOX & GOCO Class Actions: Bronstein, Gewirtz & Grossman LLC Reminds Investors of Class Actions and Upcoming Lead Plaintiff Deadlines
From GlobeNewswire News Releases
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Odonate Therapeutics, Inc. and of Class Action Lawsuit and Upcoming Deadline – ODT
From GlobeNewswire News Releases
Implied IEIH Analyst Target Price: $37
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.